9
Views
7
CrossRef citations to date
0
Altmetric

References

  • Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature [Med] 1995;1:564–9.
  • Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60–7.
  • Linnen J, Wages J, ZhangKeck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505–8.
  • Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus. N Engl J Med 1997; 336:741–6.
  • Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW-K, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;335:747–54.
  • Jarvis LM, Davidson F, Hanley JP, Yap PL, Ludlam CA, Simmonds P. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996;348:1352–5.
  • Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unkown aetiology. Lancet 1995;346:1131–2.
  • Kao JH, Chen PJ, Chen Ds. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996;347: 120.
  • Haydon GH, Jarvis LM, Simpson KJ, Hayes PC, Simmonds P. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant presumed viral hepatitis. Viral Hepatitis 1997;4:45–9.
  • Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, et al. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Scand J Infect Dis 1997;29:17–22.
  • Knodell RG, Ishak KG, Black WC, Chen JS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
  • Davidson F, Simmonds P, Ferguson JC, Jarvis LM, Dow BC, Follett EAC, et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995;76:1197–204.
  • Simmonds P, Rose KA, Graham S, Chan SW, McOmish F, Dow BC, et al. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV)—use of type-specific peptides to serologically differentiate infections with HCV type 1, type 2, and type 3. J Clin Microbiol 1993;31: 1493–503.
  • Simmonds P, Zhang LQ, Watson HG, Rebus S, Ferguson ED, Balfe P, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 1990;336: 1469–72.
  • Berg T, Dirla U, Naumann U, Heuft HG, Kuther S, Lobeck H, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996;25:763–8.
  • Bralet MP, Roudotthoraval F, Pawlotsky JM, Bastie A, Vannhieu JT, Duval J, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112:188–92.
  • Francesconi R, Giostra F, Ballardini G, Manzin A, Solforosi L, Lari F, et al. Clinical implications of GBV-C/HGV infection in patients with ‘HCV-related’ chronic hepatitis. J Hepatol 1997; 26:1165–72.
  • Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, et al. Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med 1997;126:874.
  • Saiz JC, Ampurdanes S, Olmedo E, LopezLabrador FX, Forns X, Guilera M, et al. Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy. J Hepatol 1997;26:787–93.
  • Tanaka E, Alter HJ, Nakatsuji Y, Shih JWK, Kim JP, Matsumoto A, et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996;125:740–3.
  • Nagayama R, Miyake K, Okamoto H. Effect of interferon on GB virus C and hepatitis C virus in hepatitis patients with the coinfection. J Med Virol 1997;52:156–60.
  • Yasuda K, Iino S. Effect of interferon therapy on RNA of GB virus C in the patients with chronic hepatitis who were coinfected with hepatitis C virus. Int Hepatol Commun 1997; 6:306–15.
  • Baker R, Palladino S, Kay I, Lavis N, Flexman J. Low prevalence of hepatitis G viraemia in haemophilia patients in Australia. Br J Haematol 1997;96:654–5.
  • Hanley JP, Jarvis LM, Hayes PC, Lee AJ, Simmonds P, Ludlam CA. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates. Br J Haematol 1998. In press.
  • Tagariello G, Infantolino D, Biasin MR, Davoli PG, Traldi A. Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection. Lancet 1996;348:760–1.
  • Schlauder GG, Pilot-Matias TJ, Gabriel GS, Simons JN, Muerhoff AS, Dawson GJ, et al. Origin of GB-hepatitis viruses. Lancet 1995;346:447–8.
  • Laskus T, Radkowski M, Wang L-F, Vargas H, Rakela J. Lack of evidence for hepatitis G virus replication in the livers of patients co-infected with hepatitis C and G viruses. J Virol 1997; 71:7804–6.
  • Kudo T, Morishima T, Shibata M. Hepatitis G infection. N Engl J Med 1997;337:276–7.
  • Missale G, Cariani E, Lamonaca V, Ravaggi A, Rossini A, Bertoni R, et al. Effects of interferon treatment on the antiviral T-cell response in hepatitis C virus genotype 1b- and genotype 2c-infected patients. Hepatology 1997;26:792–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.